Jeil Pharmaceutical Co.,Ltd (KRX:271980)

KRX:271980 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	51,800	53,476	32,991	31,446	25,963	3,893
Short-Term Investments	4,114	3,980	2,667	142.46	2,040	2,695
Cash & Short-Term Investments	55,914	57,455	35,658	31,589	28,003	6,588
Cash Growth	48.79%	61.13%	12.88%	12.80%	325.06%	-51.27%
Accounts Receivable	138,060	160,467	150,955	137,807	129,424	141,176
Other Receivables	3,625	13,440	15,171	15,454	15,265	15,747
Receivables	141,685	173,908	166,126	153,262	146,689	156,922
Inventory	99,190	104,427	109,768	99,151	102,458	109,311
Prepaid Expenses	230.98	214.62	327.84	291.88	186.71	167.88
Other Current Assets	15,317	7,031	5,167	7,348	7,336	4,524
Total Current Assets	312,338	343,036	317,046	291,641	284,672	277,513
Property, Plant & Equipment	147,281	146,166	137,041	138,402	125,710	115,547
Long-Term Investments	17,138	8,342	7,343	6,798	5,032	1,920
Other Intangible Assets	8,894	4,994	4,320	3,888	3,762	4,095
Long-Term Accounts Receivable	0	0	-0	0	0	-
Long-Term Deferred Tax Assets	7,442	7,428	5,359	172.39	1,452	3,321
Long-Term Deferred Charges	7,032	8,378	8,561	5,494	-	-
Other Long-Term Assets	1,535	7,356	7,656	10,496	5,858	7,267
Total Assets	501,659	525,700	487,326	456,892	426,486	409,663
Accounts Payable	81,882	134,562	144,338	151,641	153,084	143,363
Accrued Expenses	178.33	178.21	160.74	99.91	29.33	24.88
Short-Term Debt	89,523	71,000	64,772	40,576	24,166	30,419
Current Portion of Long-Term Debt	-	-	-	2,500	6,125	6,125
Current Portion of Leases	1,917	1,971	1,946	1,832	1,915	1,598
Current Income Taxes Payable	3,673	3,588	448.24	1,049	114.57	3,432
Other Current Liabilities	63,996	80,391	92,710	62,667	36,509	33,096
Total Current Liabilities	241,169	291,690	304,375	260,366	221,943	218,058
Long-Term Debt	-	-	-	3,999	8,977	7,656
Long-Term Leases	1,462	2,725	4,452	5,443	6,617	3,506
Pension & Post-Retirement Benefits	15,342	11,771	6,733	25.04	1,262	7,504
Other Long-Term Liabilities	94.11	197.01	938.52	23,170	20,339	459.46
Total Liabilities	258,067	306,383	316,499	293,003	259,139	237,184
Common Stock	7,352	7,352	7,352	7,352	7,352	7,352
Additional Paid-In Capital	206,610	206,223	155,296	155,296	155,296	149,117
Retained Earnings	-36,276	-52,296	-19,660	-20,321	-10,414	2,841
Treasury Stock	-4,829	-4,829	-4,829	-4,829	-4,432	-3,622
Comprehensive Income & Other	31,684	31,699	20,410	20,410	20,410	16,706
Total Common Equity	204,542	188,150	158,570	157,909	168,213	172,394
Minority Interest	39,049	31,167	-1,538	-2,312	-866.16	85.04
Shareholders' Equity	243,591	219,317	170,828	163,889	167,347	172,479
Total Liabilities & Equity	501,659	525,700	487,326	456,892	426,486	409,663
Total Debt	92,902	75,695	71,170	54,350	47,800	49,304
Net Cash (Debt)	-36,988	-18,240	-35,513	-22,761	-19,797	-42,716
Net Cash Per Share	-2537.76	-1251.75	-2437.13	-1561.68	-1355.11	-2922.88
Filing Date Shares Outstanding	14.58	14.57	14.57	14.57	14.58	14.61
Total Common Shares Outstanding	14.58	14.57	14.57	14.57	14.58	14.61
Working Capital	71,169	51,345	12,671	31,275	62,729	59,455
Book Value Per Share	14027.53	12912.16	10882.20	10836.83	11533.52	11800.20
Tangible Book Value	195,648	183,156	154,250	154,021	164,451	168,299
Tangible Book Value Per Share	13417.59	12569.44	10585.71	10570.02	11275.56	11519.87
Land	54,461	53,698	40,613	40,586	30,106	23,821
Buildings	67,675	105,484	103,864	103,864	102,213	102,747
Machinery	11,104	88,787	88,622	82,315	76,560	72,000
Construction In Progress	-	4,724	3,070	3,717	2,390	584.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.